Inhibitors & Activators

Inhibitors & Activators

Insulin is the principal hormone that regulates the uptake of glucose from the blood into most cells of the body, especially liver, adipose tissue and muscle, except smooth muscle, in which insulin acts via the IGF-1. The deficiency of insulin or the insensitivity of its receptors play a central role in all forms of diabetes.

Inhibitors and activators are molecules that increase or decrease the activity of enzymes or metabolites, which are critical tools for researchers in the field of cell biology to obtain a comprehensive understanding of cell function, cell signaling and the intracellular mechanisms that control cell fate, function, and phenotype.

For assisting our global customers making better progress in therapeutic development and drug discovery, Ace Therapeutics offers proteins and peptides for diabetes. As a pioneer of diabetes research, Ace Therapeutics provides the most comprehensive list of recombinant inhibitors and activators products in the world.

Inhibitors & Activators for Diabetes Research
MC-4R Agonist 1 (DIA-0243157)
  • CAS Number: 455957-28-5
  • Target: Melanocortin Receptor
Semaglutide (DIA-0243158)
  • CAS Number: 910463-68-2
  • Purity: 99.84%
  • Target: GCGR
BTI-A-404 (DIA-0243159)
  • CAS Number: 537679-57-5
  • Target: Free Fatty Acid Receptor
  • CAS Number: 912777-95-8
  • Purity: ≥98.0%
  • Target: Others
Crotedumab (DIA-0243161)
  • CAS Number: 1452387-69-7
  • Purity: 96.61%
  • Target: GCGR
α-Amylase-IN-5 (DIA-0243162)
  • CAS Number: 2996821-90-8
  • Target: Amylases
Glucose-malemide (DIA-0243163)
  • CAS Number: 2093979-63-4
  • Purity: 99.72%
  • Target: Biochemical Assay Reagents
Gliquidone-d6 (DIA-0243164)
  • Target: Isotope-Labeled Compounds
NDB (DIA-0243165)
  • CAS Number: 1660153-08-1
  • Purity: 98.94%
  • Target: FXR
Sirtuin-1 inhibitor 1 (DIA-0243166)
  • CAS Number: 945114-10-3
  • Purity: 98.09%
  • Target: Sirtuin
logo

Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.

Quick Links
Contact Info
Copyright © Ace Therapeutics. All Rights Reserved.
Top